We obtained T cells from seven unrelated ALPS patients, each with distinct dominant-negative Fas death domain mutations and typical symptoms of ALPS, including resistance of activated T cells to Fas-induced apoptosis (Supplementary Table 1). The gene discussed is FAS; the disease is autoimmune lymphoproliferative syndrome.